Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia
A Puranen, M Koponen, A Tanskanen… - European Journal of …, 2020 - Springer
Purpose Antipsychotics are first-line treatment of schizophrenia. They are often
accompanied by adjunctive treatments, such as antidepressant (AD) or mood stabilizer …
accompanied by adjunctive treatments, such as antidepressant (AD) or mood stabilizer …
Real‐world effectiveness of mood stabilizer use in schizophrenia
A Puranen, M Koponen, M Lähteenvuo… - Acta Psychiatrica …, 2023 - Wiley Online Library
Objective Mood stabilizers (MS) are often used as adjunctive medication in patients with
schizophrenia. The aim of this study was to investigate the real‐world effectiveness of MS …
schizophrenia. The aim of this study was to investigate the real‐world effectiveness of MS …
Comparative effectiveness of adjunctive psychotropic medications in patients with schizophrenia
Importance People with schizophrenia are commonly treated with psychotropic medications
in addition to antipsychotics, but there is little evidence about the comparative effectiveness …
in addition to antipsychotics, but there is little evidence about the comparative effectiveness …
Discontinuation of antipsychotics in individuals with first-episode schizophrenia and its association to functional outcomes, hospitalization and death: a register-based …
AE Stürup, M Nordentoft, E Jimenez-Solem… - Psychological …, 2023 - cambridge.org
BackgroundDiscontinuation of antipsychotic medication may be linked to high risk of
relapse, hospitalization and mortality. This study investigated the use and discontinuation of …
relapse, hospitalization and mortality. This study investigated the use and discontinuation of …
[HTML][HTML] Antipsychotic prescribing patterns in first-episode schizophrenia: a five-year comparison
D Roh, JG Chang, S Yoon, CH Kim - Clinical Psychopharmacology …, 2015 - ncbi.nlm.nih.gov
Objective Early treatment choice is critical in first-episode schizophrenia-spectrum disorders.
The purpose of this study was to describe prescribing trends of antipsychotics use in patients …
The purpose of this study was to describe prescribing trends of antipsychotics use in patients …
Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects
A Puranen, M Koponen, M Lähteenvuo, A Tanskanen… - Schizophrenia, 2023 - nature.com
The aim of this study was to investigate the real-world effectiveness of antidepressant use in
persons with schizophrenia. The register-based study cohort included all 61,889 persons …
persons with schizophrenia. The register-based study cohort included all 61,889 persons …
Adjunctive mood stabilizer and benzodiazepine use in older Asian patients with schizophrenia, 2001–2009
YT Xiang, F Dickerson, J Kreyenbuhl… - …, 2012 - thieme-connect.com
This study surveyed the use of adjunctive mood stabilizers (MS) and benzodiazepines (BZD)
in older Asian schizophrenia patients and examined their demographic and clinical …
in older Asian schizophrenia patients and examined their demographic and clinical …
Antipsychotic treatment and risk of discontinuation and hospitalization in first-episode schizophrenia: a nationwide population-based study
SW Joo, H Kim, YT Jo, YJ Choi, S Ahn… - Psychological Medicine, 2023 - cambridge.org
Background Current evidence on antipsychotic treatment and risk of psychiatric
hospitalization in first-episode schizophrenia (FES) is largely based on the findings from …
hospitalization in first-episode schizophrenia (FES) is largely based on the findings from …
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
YM Mao, MD Zhang - Neuropsychiatric disease and treatment, 2015 - Taylor & Francis
We focused on the application of antidepressants in schizophrenia treatment in this review.
Augmentation of antidepressants with antipsychotics is a common clinical practice to treat …
Augmentation of antidepressants with antipsychotics is a common clinical practice to treat …
Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST)
Background This study had two aims: to describe patients suffering from first-episode
schizophrenia who had stopped taking any antipsychotic medication, and to gain …
schizophrenia who had stopped taking any antipsychotic medication, and to gain …